AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/article-1G1-148363181/plant-test-new-production.html" title="Facts and information about Plant to test new production method.">Plant to test new production method.</a>

Close Set up an RSS feed that alerts you when new articles from The News & Observer (Raleigh, NC) are available.

Frequently asked questions about RSS feeds

Plant to test new production method.

The News & Observer (Raleigh, NC)

| July 19, 2006 | COPYRIGHT 2007 The News & Observer. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Byline: Sabine Vollmer

Jul. 19--Holly Springs is set to become a proving ground -- for Novartis and the next generation of vaccines. The plant the Swiss drug maker is proposing to build in the booming bedroom community southwest of Raleigh will manufacture flu vaccines with a new technique that could produce vaccines faster in case of a pandemic. The plant could be the first of its kind. It's also a first for Novartis, which is Europe's third-largest drug maker and better known for brand-name drugs such as cancer treatment Gleevec, generic drugs including Prilosec to relieve heartburn, Ciba Vision contact lenses and Gerber baby food. In North Carolina, the company already has a facility…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


USA' HHS awards contracts totaling over $1B to develop cell-based flu...: Newspaper article from: Pharma Marketletter May 15, 2006 700+ words
...vaccines and will help to modernize and strengthen the nation's flu vaccine production by creating an alternative to making the products...virus strains to grow in eggs. In addition, cell culture-based flu vaccines will help meet surge capacity needs in the event...


HHS hedges bets on cell-based flu vaccine: $487 million contract awarded for...: Magazine article from: Medicine & Health February 6, 2009 700+ words
...preparing the nation for a pandemic. That goal could not be accomplished using the traditional egg-based method of producing flu vaccine." Another perk: New cell-based influenza vaccines provide an option for people who are allergic to eggs and, therefore...


U.S. to produce cell-based flu vaccine.: News wire article from: UPI NewsTrack January 15, 2009 700+ words
...UPI) -- The U.S. government said it has awarded a $487 million contract to Novartis Vaccines and Diagnostics for cell-based flu vaccines. Novartis will be the first U.S. facility to manufacture cell-based vaccines, which can be made faster and...


MedImmune wins 5-yr, $170M cell-based flu vaccine contract.: News wire article from: The America's Intelligence Wire May 4, 2006 700+ words
...million doses within six months of notification of a flu pandemic. MedImmune also plans to start in June its first Phase 1 bird flu vaccine study. The company expects the Food and Drug Administration to respond in July regarding data in its supplemental biologic...


DNA-Based Flu Vaccine Raises Protective Immunity; Could be Model for Other...: Newspaper article from: Vaccine Weekly September 20, 2000 700+ words
2000 SEP 20 - (NewsRx.com) -- Scientists at the Vaccine Research Center of Emory University, Atlanta, Georgia, have successfully engineered and tested a single-dose, DNA-based influenza vaccine in mice that could serve as a template for more effective vaccines against a variety of viral illnesses,


DNA-Based Flu Vaccine Raises Protective Immunity; Could be Model for Other...: Newspaper article from: Virus Weekly September 19, 2000 700+ words
2000 SEP 19 - (NewsRx.com) -- Scientists at the Vaccine Research Center of Emory University, Atlanta, Georgia, have successfully engineered and tested a single-dose, DNA-based influenza vaccine in mice that could serve as a template for more effective vaccines against a variety of viral illnesses,


PowderMed's DNA-Based Flu Vaccine Shows Cross-Protective Immunity against...: Press release article from: Business Wire December 19, 2005 700+ words
WASHINGTON & OXFORD, United Kingdom -- Results of Phase 1 Clinical Trial Presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Since the circulating influenza strains for any given season cannot be precisely predicted, an effective influenza vaccine should be


PowderMed's DNA-based flu vaccine shows cross-protective immunity against...: News wire article from: Chemical Business Newsbase December 19, 2005 700+ words
(From Chemical Business NewsBase - Press Release) Since the circulating influenza strains for any given season cannot be precisely predicted, an effective influenza vaccine should be able to generate protection for both the genetically identical (homologous) strain of flu as well as


Study in the journal VACCINE reports positive results of DNA-based flu vaccine...: News wire article from: Chemical Business Newsbase May 31, 2006 700+ words
(From Chemical Business NewsBase - Press Release) PowderMed Ltd announced the publication of positive results from a Phase I study evaluating its proprietary prophylactic DNA influenza vaccine in the latest issue (volume 24, issue 21) of the journal Vaccine. Based on these results, PowderMed will


Study in the Journal VACCINE Reports Positive Results of DNA-Based Flu Vaccine...: Press release article from: Business Wire May 31, 2006 700+ words
OXFORD, United Kingdom and FREDERICK, Md. -- PowderMed, Ltd. today announced the publication of positive results from a Phase I study evaluating its proprietary prophylactic DNA influenza vaccine in the latest issue (volume 24, issue 21) of the journal VACCINE. Based on these results, PowderMed

For more facts and information, see all results

The AccessMyLibrary advertising network includes: